title: Ofatumumab: a novel treatment for severe systemic lupus erythematosus.
authors.affiliation: Department of Rheumatology and Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, UK.
authors.forename: C Clare
authors.initials: CC
authors.lastname: Thornton
authors.affiliation: Department of Rheumatology and Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, UK.
authors.forename: Nicola
authors.initials: N
authors.lastname: Ambrose
authors.affiliation: Department of Rheumatology and Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, UK. y.ioannou@ucl.ac.uk.
authors.forename: Yiannis
authors.initials: Y
authors.lastname: Ioannou
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018951:Antigens, CD20 / Q000276:immunology; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018951:Antigens, CD20; C527517:ofatumumab